Gujarat Themis Biosyn Ltd
BSE:506879
Gujarat Themis Biosyn Ltd
Gross Profit
Gujarat Themis Biosyn Ltd
Gross Profit Peer Comparison
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Gujarat Themis Biosyn Ltd
BSE:506879
|
Gross Profit
₹953.2m
|
CAGR 3-Years
4%
|
CAGR 5-Years
42%
|
CAGR 10-Years
23%
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Gross Profit
₹192B
|
CAGR 3-Years
15%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
Cipla Ltd
NSE:CIPLA
|
Gross Profit
₹165.2B
|
CAGR 3-Years
12%
|
CAGR 5-Years
10%
|
CAGR 10-Years
11%
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Gross Profit
₹369.1B
|
CAGR 3-Years
15%
|
CAGR 5-Years
12%
|
CAGR 10-Years
11%
|
|
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
|
Gross Profit
₹123.7B
|
CAGR 3-Years
9%
|
CAGR 5-Years
8%
|
CAGR 10-Years
11%
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Gross Profit
₹77.6B
|
CAGR 3-Years
10%
|
CAGR 5-Years
8%
|
CAGR 10-Years
11%
|
See Also
What is Gujarat Themis Biosyn Ltd's Gross Profit?
Gross Profit
953.2m
INR
Based on the financial report for Dec 31, 2023, Gujarat Themis Biosyn Ltd's Gross Profit amounts to 953.2m INR.
What is Gujarat Themis Biosyn Ltd's Gross Profit growth rate?
Gross Profit CAGR 10Y
23%
Over the last year, the Gross Profit growth was -18%. The average annual Gross Profit growth rates for Gujarat Themis Biosyn Ltd have been 4% over the past three years , 42% over the past five years , and 23% over the past ten years .